TraxStar Launches SynQ: A Platform for Designing Fully Custom Lab Workflows
December 11, 2025
WALNUT CREEK, Calif. -- TraxStar, a leader in laboratory management software for discrete manufacturing, announces the release of SynQ, a powerful new platform that enables organizations to design custom resources and workflows with virtually no limitations. Built for teams that need more than traditional LIMS can offer, SynQ empowers users to create digital workflows without [...]
Medra Raises $52 Million Series A to Build Physical AI Scientists
December 11, 2025
Pioneering the next era of discovery by integrating AI algorithms with robotics execution to reinvent how new medicines are designed. SAN FRANCISCO -- Medra, the company developing the first platform for Physical AI Scientists, today announced a $52 million Series A financing led by Human Capital, with participation from existing investors Lux Capital, Neo, and [...]
December 11, 2025
Parse’s GigaLab to provide industry leading, large-scale, single cell services to support Tahoe’s development of foundational biological datasets SEATTLE — Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, today announced that Tahoe Therapeutics has selected Parse’s GigaLab to generate data for its upcoming 300M cell project. Tahoe will use its proprietary Mosaic technology to [...]
December 11, 2025
New priority program opens up exclusive opportunities for collaborative research on transformative clinical potential of DNAe's flagship tests and to gain preview of breakthrough LiDia-SEQ™ platform LONDON and CARLSBAD, Calif. -- DNAe, the Next-Generation Sequencing (NGS) company developing a transformative fully automated, sample-to-report diagnostics platform, today unveils a new Early Access Program, offering clinical partners an exclusive pre-launch preview of [...]
Certara Appoints Jon Resnick as Chief Executive Officer
December 11, 2025
Resnick brings decades of leadership experience in health sciences, business operations, strategy, innovation and commercial growth William Feehery to step down as CEO on December 31, 2025 Company reaffirms full year 2025 financial outlook RADNOR, Pa. -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, announced today that it has appointed Jon [...]
Sapio Sciences Partners with the Wellcome Sanger Institute on Digital Laboratory Transformation
December 10, 2025
Mike Hampton, Chief Commercial Officer, Sapio Sciences Sapio Sciences, the science-awareTM AI lab informatics platform, today announced that the Wellcome Sanger Institute has selected the Sapio Informatics Platform as its central LIMS to underpin the Institute's ambitious lab transformation program. The Sanger Institute will move from a patchwork of legacy LIMS solutions to a foundation centered on Sapio LIMS to support large-scale [...]
December 10, 2025
ETTLINGEN, Germany -- Bruker Corporation (Nasdaq: BRKR) today announced several significant European orders for high-performance magnetic resonance systems from three leading research institutions in France and Germany: AVANCE NEO 1 GHz system with a range of liquids and solids NMR probes for biological and material science applications In the summer, École Normale Supérieure (ENS-PSL) in Paris, France ordered [...]
December 10, 2025
Simoa® HD-X Receives MFDS Class I IVD Import Clearance, Enabling the First Clinical Introduction of Simoa® Technology in Korea Seoul, Republic of Korea – Quanterix Corporation (NASDAQ: QTRX), a U.S.-based biotechnology company specializing in ultrasensitive biomarker detection, and its clinical diagnostics brand Lucent Diagnostics, together with Emocog Inc. (Co-CEOs Jun-Young Lee and Yoo-Hun Noh), a digital [...]
December 10, 2025
With this approval, Roche’s automated mass spectrometry platform now offers the industry’s broadest in vitro diagnostic menu with 39 tests, including tests for therapeutic drug monitoring for immunosuppressants and antibiotics, as well as steroid hormones and vitamin D metabolites. The comprehensive menu brings the sensitivity and specificity of gold-standard testing into routine labs for a [...]
BenchSci Extends ASCEND Agreement with Merck to Support Preclinical Disease Biology Research
December 9, 2025
Toronto — BenchSci, a leading provider of AI software for biopharma research and development, today announced a renewed two-year contract with Merck, known as MSD outside of the United States and Canada. “Seeing Merck’s teams use ASCEND to unravel disease biology, strengthen hypotheses, and make more evidence-driven decisions underscores the real scientific value AI can [...]

